Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cells

Journal of Immunological Methods

Volumn 345, Issue 1-2, 2009, Pages 49-59

  Shiratsuchi, Takayuki ^a   Schneck, Jonathan ^b   Kawamura, Akira ^c   Tsuji, Moriya ^a  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Artificial antigen presenting cells; CD1; Lipid antigen; NKT cells

Indexed keywords

BETA 2 MICROGLOBULIN; CD1 ANTIGEN; CD28 ANTIGEN; IMMUNOGLOBULIN G1;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MEDICAL RESEARCH; MOLECULE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; ANTIGENS, PROTOZOAN; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPIDS; MICE; NATURAL KILLER T-CELLS; PLASMODIUM YOELII; PROTEIN MULTIMERIZATION; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTE SUBSETS;

MURINAE;

EID: 67349264064     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.04.002     Document Type: Article

References (47)

1. Agea E., Russano A., Bistoni O., Mannucci R., Nicoletti I., Corazzi L., Postle A.D., De Libero G., Porcelli S.A., and Spinozzi F. Human CD1-restricted T cell recognition of lipids from pollens. J. Exp. Med. 202 (2005) 295
2. Antes I., Siu S.W., and Lengauer T. DynaPred: a structure and sequence based method for the prediction of MHC class I binding peptide sequences and conformations. Bioinformatics 22 (2006) e16
3. Barral D.C., and Brenner M.B. CD1 antigen presentation: how it works. Nat. Rev., Immunol. 7 (2007) 929
4. Beckman E.M., Porcelli S.A., Morita C.T., Behar S.M., Furlong S.T., and Brenner M.B. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372 (1994) 691
5. Bradbury A., Belt K.T., Neri T.M., Milstein C., and Calabi F. Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO J. 7 (1988) 081
6. Brigl M., and Brenner M.B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22 (2004) 817
7. Cantu III C., Benlagha K., Savage P.B., Bendelac A., and Teyton L. The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs. J. Immunol. 170 (2003) 4673
8. Cerundolo V., Silk J.D., Masri S.H., and Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev., Immunol. 9 (2009) 28
9. Dal Porto J., Johansen T.E., Catipovic B., Parfiit D.J., Tuveson D., Gether U., Kozlowski S., Fearon D.T., and Schneck J.P. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 6671
10. Dascher C.C., Hiromatsu K., Naylor J.W., Brauer P.P., Brown K.A., Storey J.R., Behar S.M., Kawasaki E.S., Porcelli S.A., Brenner M.B., and LeClair K.P. Conservation of a CD1 multigene family in the guinea pig. J. Immunol. 163 (1999) 5478
11. Dascher C.C., Hiromatsu K., Xiong X., Morehouse C., Watts G., Liu G., McMurray D.N., LeClair K.P., Porcelli S.A., and Brenner M.B. Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int. Immunol. 15 (2003) 915
12. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497
13. Forestier C., Molano A., Im J.S., Dutronc Y., Diamond B., Davidson A., Illarionov P.A., Besra G.S., and Porcelli S.A. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice. J. Immunol. 175 (2005) 763
14. Gonzalez-Aseguinolaza G., Van Kaer L., Bergmann C.C., Wilson J.M., Schmieg J., Kronenberg M., Nakayama T., Taniguchi M., Koezuka Y., and Tsuji M. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195 (2002) 617
15. Grant E.P., Degano M., Rosat J.P., Stenger S., Modlin R.L., Wilson I.A., Porcelli S.A., and Brenner M.B. Molecular recognition of lipid antigens by T cell receptors. J. Exp. Med. 189 (1999) 195
16. Huang M.M., Borszcz P., Sidobre S., Kronenberg M., and Kane K.P. CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1. J. Immunol. 172 (2004) 5304
17. Hiromatsu K., Dascher C.C., LeClair K.P., Sugita M., Furlong S.T., Brenner M.B., and Porcelli S.A. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J. Immunol. 169 (2002) 330
18. Im J.S., Yu K.O., Illarionov P.A., LeClair K.P., Storey J.R., Kennedy M.W., Besra G.S., and Porcelli S.A. Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes. J. Biol. Chem. 279 (2004) 299
19. Kang S.J., and Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 175 (2004)
20. Kaser A., Hava D.L., Dougan S.K., Chen Z., Zeissig S., Brenner M.B., and Blumberg R.S. Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules. Eur. J. Immunol. 38 (2008) 2351
21. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626
22. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., Kondo E., Harada M., Koseki H., Nakayama T., Tanaka Y., and Taniguchi M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5690
23. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., Zajonc D.M., Ben-Menachem G., Ainge G.D., Painter G.F., Khurana A., Hoebe K., Behar S.M., Beutler B., Wilson I.A., Tsuji M., Sellati T.J., Wong C.H., and Kronenberg M. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7 (2006) 978
24. Lantz O., and Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 180 (1994) 1097
25. Marchesini N., Luo S., Rodrigues C.O., Moreno S.N., and Docampo R. Acidocalcisomes and a vacuolar H+-pyrophosphatase in malaria parasites. Biochem. J. 347 (2000) 243
26. Miyamoto K., Miyake S., and Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413 (2001) 531
27. Moody D.B., Ulrichs T., Mühlecker W., Young D.C., Gurcha S.S., Grant E., Rosat J.P., Brenner M.B., Costello C.E., Besra G.S., and Porcelli S.A. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404 (2000) 884
28. Naidenko O.V., Maher J.K., Ernst W.A., Sakai T., Modlin R.L., and Kronenberg M. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med. 190 (1999) 1069
29. Nieuwenhuis E.E., Matsumoto T., Exley M., Schleipman R.A., Glickman J., Bailey D.T., Corazza N., Colgan S.P., Onderdonk A.B., and Blumberg R.S. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 588 (2002)
30. Oelke M., Maus M.V., Didiano D., June C.H., Mackensen A., and Schneck J.P. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat. Med. 9 (2003) 619
31. Prigozy T.I., Naidenko O., Qasba P., Elewaut D., Brossay L., Khurana A., Natori T., Koezuka Y., Kulkarni A., and Kronenberg M. Glycolipid antigen processing for presentation by CD1d molecules. Science 291 (2001) 664
32. Rauch J., Gumperz J., Robinson C., Sköld M., Roy C., Young D.C., Lafleur M., Moody D.B., Brenner M.B., Costello C.E., and Behar S.M. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J. Biol. Chem. 278 (2003) 47508
33. Rosat J.P., Grant E.P., Beckman E.M., Dascher C.C., Sieling P.A., Frederique D., Modlin R.L., Porcelli S.A., Furlong S.T., and Brenner M.B. CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J. Immunol. 162 (1999) 366
34. Russano A.M., Bassotti G., Agea E., Bistoni O., Mazzocchi A., Morelli A., Porcelli S.A., and Spinozzi F. CD1-restricted recognition of exogenous and self-lipid antigens by duodenal gammadelta+ T lymphocytes. J. Immunol. 178 (2007) 3620
35. Schmieg J., Yang G., Franck R.W., and Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. J. Exp. Med. 198 (2003) 1631
36. Shamshiev A., Gober H.J., Donda A., Mazorra Z., Mori L., and De Libero G. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195 (2002) 1013
37. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Sondhi J., Naidenko O.V., Kronenberg M., Koezuka Y., Delovitch T.L., Gombert J.M., Leite-De-Moraes M., Gouarin C., Zhu R., Hameg A., Nakayama T., Taniguchi M., Lepault F., Lehuen A., Bach J.F., and Herbelin A. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7 (2001) 1057
38. Sieling P.A., Chatterjee D., Porcelli S.A., Prigozy T.I., Mazzaccaro R.J., Soriano T., Bloom B.R., Brenner M.B., Kronenberg M., Brennan P.J., et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269 (1995) 227
39. Tsuji M. Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands. Cell. Mol. Life Sci. 63 (2006) 1889
40. Tubbs K.A., Nedelkov D., and Nelson R.W. Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay. Anal. Biochem. 289 (2001) 26
41. Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19 (2007) 354
42. Vincent M.S., Xiong X., Grant E.P., Peng W., and Brenner M.B. CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. J. Immunol. 175 (2005) 6344
43. Webb T.J., Giuntoli II R.L., Rogers O., Schneck J., and Oelke M. Ascites specific inhibition of CD1d-mediated activation of natural killer T cells. Clin. Cancer Res. 14 (2008) 7652
44. Winau F., Schwierzeck V., Hurwitz R., Remmel N., Sieling P.A., Modlin R.L., Porcelli S.A., Brinkmann V., Sugita M., Sandhoff K., Kaufmann S.H., and Schaible U.E. Saposin C is required for lipid presentation by human CD1b. Nat. Immunol. 5 (2004) 169
45. Wu D.Y., Segal N.H., Sidobre S., Kronenberg M., and Chapman P.B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198 (2003) 173
46. Yu K.O., Im J.S., Molano A., Dutronc Y., Illarionov P.A., Forestier C., Fujiwara N., Arias I., Miyake S., Yamamura T., Chang Y.T., Besra G.S., and Porcelli S.A. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3383
47. Zhou D., Cantu III C., Sagiv Y., Schrantz N., Kulkarni A.B., Qi X., Mahuran D.J., Morales C.R., Grabowski G.A., Benlagha K., Savage P., Bendelac A., and Teyton L. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303 (2004) 523